Sidney Taurel, the chairman and CEO of Eli Lilly, has a sunny outlook on the progress in biomedical research. In the Boston Herald, he writes that this field has not fizzled out but is on the verge of discovering answers and cures to many diseases -- and it will be almost "miraculous." He notes that "human mortality will always equal 100 percent," but he sure seems confident that Lilly scientists will overcome all problems right up until the end. Or maybe he's just looking for new stockholders.
Mar 12, 2007